<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Atrophic <z:hpo ids='HP_0005263'>gastritis</z:hpo> of the corporal mucosa is a frequent cause of hypergastrinemia </plain></SENT>
<SENT sid="1" pm="."><plain>Hypergastrinemia is implicated in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> development </plain></SENT>
<SENT sid="2" pm="."><plain>AIM: To assess whether hypergastrinemic atrophic <z:hpo ids='HP_0005263'>gastritis</z:hpo> is associated with a higher risk of neoplastic colorectal lesions </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Among 441 hypergastrinemic atrophic <z:hpo ids='HP_0005263'>gastritis</z:hpo> patients, 160 who were aged &gt;40 and underwent colonoscopy for <z:hpo ids='HP_0001903'>anaemia</z:hpo>, diarrhoea or <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>-screening were retrospectively selected </plain></SENT>
<SENT sid="4" pm="."><plain>Each patient was age- and gender-matched with a normogastrinemic control with healthy stomach </plain></SENT>
<SENT sid="5" pm="."><plain>Controls had colonoscopy, gastroscopy with biopsies and gastrin assessment </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: 160 hypergastrinemic atrophic <z:hpo ids='HP_0005263'>gastritis</z:hpo> patients and 160 controls were included </plain></SENT>
<SENT sid="7" pm="."><plain>28 atrophic <z:hpo ids='HP_0005263'>gastritis</z:hpo> patients and 36 controls had neoplastic colorectal lesions (p=0.33) </plain></SENT>
<SENT sid="8" pm="."><plain>Patients and controls did not differ for frequency of colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> (10.6% vs. 13.1%, p=0.60) or <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (6.9% vs. 9.4%, p=0.54) </plain></SENT>
<SENT sid="9" pm="."><plain>Hypergastrinemic atrophic <z:hpo ids='HP_0005263'>gastritis</z:hpo> was not associated with a higher probability of developing <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (OR 1.03, 95% CI 0.34-3.16) </plain></SENT>
<SENT sid="10" pm="."><plain>Age &gt;50 years (OR 3.86) but not hypergastrinemia (OR 0.61) was associated with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Hypergastrinemic atrophic <z:hpo ids='HP_0005263'>gastritis</z:hpo> is not associated with higher risk for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Atrophic <z:hpo ids='HP_0005263'>gastritis</z:hpo>-related hypergastrinemia is not associated with an increased risk of neoplastic colorectal lesions </plain></SENT>
<SENT sid="13" pm="."><plain>Closer surveillance of colonic <z:hpo ids='HP_0002664'>neoplasia</z:hpo> in atrophic <z:hpo ids='HP_0005263'>gastritis</z:hpo> patients seems not appropriate </plain></SENT>
</text></document>